Revelation Biosciences Inc (REVB) — Cash Flow Reinvestment Rate
Revelation Biosciences Inc (REVB) has a Cash Flow Reinvestment Rate of 2.22x as of December 2018, reinvesting $18.70 Million (capex $349.00K plus investments $-18.35 Million) from operating cash flow of $8.43 Million. See REVB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Revelation Biosciences Inc Cash Flow Reinvestment Rate (2015–2019)
Historical reinvestment intensity for Revelation Biosciences Inc across 5 annual periods. For the full cash flow conversion analysis, see REVB cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Revelation Biosciences Inc (2015–2019)
Year-by-year capital reinvestment analysis for Revelation Biosciences Inc. See Revelation Biosciences Inc (REVB) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 8.98x | $369.13 Million | $41.09 Million | $526.00K | ▼ -1.0% |
| 2018 | 9.08x | $295.71 Million | $32.58 Million | $861.00K | ▼ -12.8% |
| 2017 | 10.41x | $252.40 Million | $24.25 Million | $804.00K | ▼ -38.8% |
| 2016 | 17.01x | $197.25 Million | $11.60 Million | $582.00K | ▲ +511.2% |
| 2015 | 2.78x | $32.27 Million | $11.60 Million | $582.00K | — |